田中明人

タナカアキト | Tanaka Akito

所属機関・部署：
職名：教授

研究分野 (2件)：薬系化学、創薬科学 , 生物有機化学

研究キーワード (1件)： huhs015

競争的資金等の研究課題 (1件)：

論文 (52件)：

Tadashi Shimizu, Keiko Yamaguchi, Momoka Yamamoto, Rina Kurioka, Yukari Kino, Wataru Matsunaga, Syuhei Nakao, Hiroshi Fukuhara, Akito Tanaka, Akinobu Gotoh, et al. Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug. Bioorganic & medicinal chemistry letters. 2020. 30. 1. 126744-126744
Masahiro Ueda, Tadashi Shimizu, Miyuki Mabuchi, Kota Horiike, Kaori Kitae, Hiroaki Hase, Yuko Ueda, Kazutake Tsujikawa, Akito Tanaka. Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells In Vivo. Anticancer research. 2018. 38. 1. 211-218
Syuhei Nakao, Miyuki Mabuchi, Shenglan Wang, Yoko Kogure, Tadashi Shimizu, Koichi Noguchi, Akito Tanaka, Yi Dai. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. Bioorganic & medicinal chemistry letters. 2017. 27. 14. 3167-3172
Taisuke Uehara, Yukinori Minoshima, Koji Sagane, Naoko Hata Sugi, Kaoru Ogawa Mitsuhashi, Noboru Yamamoto, Hiroshi Kamiyama, Kentaro Takahashi, Yoshihiko Kotake, Mai Uesugi, et al. Selective degradation of splicing factor CAPERα by anticancer sulfonamides. Nature chemical biology. 2017. 13. 6. 675-680
Miyuki Mabuchi, Masahiro Ueda, Yuri Yoshida, Kota Horiike, Kenta Yamaoka, Syuhei Nakao, Tadashi Shimizu, Yuko Ueda, Kazutake Tsujikawa, Akito Tanaka. Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model. Anticancer research. 2017. 37. 4. 1665-1676

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

田中 明人